絞り込み

16732

広告

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone.

著者 Palmerini E , Jones RL , Marchesi E , Paioli A , Cesari M , Longhi A , Meazza C , Coccoli L , Fagioli F , Asaftei S , Grignani G , Tamburini A , Pollack SM , Picci P , Ferrari S
BMC Cancer.2016 ; 16(1):280.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (4view , 0users)

Full Text Sources

Medical

Miscellaneous

Other Literature Sources

Few new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G) plus docetaxel (D) in patients with relapsed high-grade osteosarcoma and high-grade spindle cell sarcoma of bone (HGS).
PMID: 27098543 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード